EU medicines agency not suited to perform device evaluations, says commission report
This article was originally published in Clinica
A European Commission-mandated report on the performance of the European Medicines Agency has pointed out that the agency, “at this stage, is not suited to perform [the] evaluation of all medical devices".
You may also be interested in...
Swissmedic will scale back its review procedure for certain anti-infectives if the indications for which approval is being sought are identical to those approved in the EU or the US.
Based on the operational experience gained using the new international standard for reporting suspected adverse reactions in EudraVigilance, the EU has decided to set a date for its mandatory use.
The UK’s Health Research Authority has agreed in principle to implement a new policy that aims to drive a lasting change in clinical trial transparency. Not everyone is convinced.